Join our free webcast on August 27 (11:00 to noon EST).
Our expert panel includes a pediatric emergency department doctor, a pediatric respirologist, and a parent of a child with asthma – a parent who happens to be a teacher, too!
Our certified respiratory
educators are ready to take your questions
Oct 05, 2015
Toronto, ON – World renowned asthma research pioneer Paul O’Byrne has been elected a Fellow of the Canadian Academy of Health Sciences (CAHS), one of the highest honours for members of the Canadian health sciences community. CAHS Fellows are recognized for their innovative leadership, research excellence and commitment to advancing academic health science.
Dr. O’Byrne, who is director of the Firestone Institute for Respiratory Health and chair of the Department of Medicine at McMaster University in Hamilton, Ontario, is internationally recognized for his work establishing the link between asthma and allergies. He is principal investigator for the Allergen Clinical Investigator Collaborative, a nationwide network of researchers studying the role of environmental allergens in the development of asthma.
“People like Paul exemplify the research excellence that exists within Canada,” said Dr. John Granton, national chair of The Lung Association Breathing as One Campaign for Lung Research. “We congratulate him on becoming a CAHS Fellow and, in doing so, pay tribute to his contributions to the field and impact that his work has had on patients with lung disease.”
Dr. Granton said that respiratory health professionals are deeply concerned about the lack of funding for ongoing research and education. As part of the Breathing as One Campaign, a new national training program will address the urgent need to support training of the highest calibre for respiratory researchers with multi-disciplinary expertise, nurturing them as future leaders in the field and fostering their transition to successful independent investigators.
Built around the three pillars of the new National Respiratory Research Strategy, the Breathing as One Campaign will push beyond the traditional boundaries of lung research, leveraging new knowledge and creating the highest standards of both treatment and knowledge sharing, in order to attract and retain the brightest medical minds.
Announcing Dr. O’Byrne’s appointment, CAHS said he was internationally recognized for seminal contributions into understanding the causes and treatment of asthma, including the first studies of the central role of airway inflammation in its initiation and persistence. “His studies of asthma treatment have influenced treatment guidelines worldwide.”
More Information: Monica Kocsmaros 416-864-9911 ext. 292 | email@example.com